KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Net Income (2016 - 2025)

Historic Net Income for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Bristol Myers Squibb's Net Income rose 8065.84% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year increase of 18342.76%. This contributed to the annual value of -$8.9 billion for FY2024, which is 21110.7% down from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Net Income is $2.2 billion, which was up 8065.84% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Net Income ranged from a high of $2.5 billion in Q1 2025 and a low of -$11.9 billion during Q1 2024
  • For the 5-year period, Bristol Myers Squibb's Net Income averaged around $970.3 million, with its median value being $1.7 billion (2024).
  • As far as peak fluctuations go, Bristol Myers Squibb's Net Income skyrocketed by 142625.0% in 2021, and later plummeted by 62527.57% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Net Income stood at $2.4 billion in 2021, then decreased by 14.63% to $2.0 billion in 2022, then dropped by 12.99% to $1.8 billion in 2023, then plummeted by 95.69% to $76.0 million in 2024, then skyrocketed by 2788.16% to $2.2 billion in 2025.
  • Its Net Income stands at $2.2 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $2.5 billion for Q1 2025.